Ditemukan 951 dokumen dengan kata kunci 6384 |
Simpan CSV  |
Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis
|
|
Dietary patterns and gastric cancer risk: a systematic review and meta-analysis
|
|
Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis
|
No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.21, 6 November 2013: p.1600-1607 |
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies
|
|
Synbindin in Extracellular Signal-Regulated Protein Kinase Spatial Regulation and Gastric Cancer Aggressiveness
|
No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.22, 20 November 2013: p.1738-1749 |
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
Her2/neu testing in gastric cancer: evaluating the risk of sampling errors
|
|
Postpartum Remodeling, Lactation, and Breast Cancer Risk: Summary of a National Cancer Institute–Sponsored Workshop
|
No. Panggil: JNCI Journal of the National Cancer Institute;Volume 105, No.3, 6 February, 2013: p.166-174 |
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
Risk factors for foot ulceration and lower extremity amputation in adults with end-stage renal disease on dialysis: a systematic review and meta-analysis
|
No. Panggil: Neophorlogy Dialysis Transplantation; Volume 30, No.10, October 2015: p.1747–1766 |
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
Active Smoking and Breast Cancer Risk: Original Cohort Data and Meta-Analysis
|
No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.8, 17 April, 2013: p.515-525 |
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
|
|